Lv2
200 积分 2024-04-15 加入
Body Mass Index and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies
2个月前
已完结
Mechanisms and possible hepatoprotective effects of glucagon-like peptide-1 receptor agonists and other incretin receptor agonists in non-alcoholic fatty liver disease
2个月前
已完结
The therapeutic potential of GLP-1 receptor biased agonism
3个月前
已关闭
Regulation of GLP-1 and Glucagon Receptor Function by β-Arrestins in Metabolically Important Cell Types
3个月前
已完结
Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond
3个月前
已完结
Glucagon-like peptide-1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity
3个月前
已完结
Body weight regulation models in humans: insights for testing their validity
3个月前
已完结
Epidemiology and determinants of obesity in China
4个月前
已完结
Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes
5个月前
已完结
Mazdutide versus placebo in Chinese adults with type 2 diabetes
5个月前
已完结
皖公网安备34019202002308
